down arrow

Sandu Pharma.

  • Market Cap: Micro Cap
  • Industry: Trading
  • ISIN: INE751D01014
  • NSEID:
  • BSEID: 524703
INR
49.48
1.49 (3.1%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 1.2 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

47.0050.98

52 Week

43.7569.50
Valuation
Technical
Day's Volume

CASH

1.2 k (-18.02%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.01%

Held by 0 DIIs

Promoter

42.90%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 3.60%

  • Poor long term growth as Net Sales has grown by an annual rate of 6.88% and Operating profit at 17.29% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.91
2

Flat results in Sep 24

 
3

Stock is technically in a Bearish range

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Trading

stock-summary
Market cap

INR 46 Cr (Micro Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

22

stock-summary
Dividend Yield

1.67%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

3.60%

stock-summary
Price to Book

1.14

Revenue and Profits (1 Year):
Net Sales:
18 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.67%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-16.98%
0%
-16.98%
1 Year
-24.49%
1.31%
-23.18%
2 Years
-19.65%
2.64%
-17.01%
3 Years
-31.52%
3.12%
-28.4%
4 Years
47.04%
6.59%
53.63%
5 Years
287.17%
16.56%
303.73%

Latest dividend: 0.8000000000000002 per share ex-dividend date: Sep-19-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.88%
EBIT Growth (5y)
17.29%
EBIT to Interest (avg)
1.91
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.65
Tax Ratio
29.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
4.84%
ROE (avg)
3.60%
Valuation key factors
Factor
Value
P/E Ratio
32
Industry P/E
22
Price to Book Value
1.14
EV to EBIT
24.61
EV to EBITDA
17.92
EV to Capital Employed
1.14
EV to Sales
0.64
PEG Ratio
0.53
Dividend Yield
1.67%
ROCE (Latest)
4.65%
ROE (Latest)
3.60%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Umesh Bhaskar Sandu (14.37%)

Highest Public shareholder

Sanmark Realty And Finance Private Limited (5.63%)

Individual Investors Holdings

35.34%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 3.79% vs 3.81% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 12.00% vs 194.12% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.37",
          "val2": "17.70",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.99",
          "val2": "0.91",
          "chgp": "8.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.03",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.56",
          "val2": "0.50",
          "chgp": "12.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.39%",
          "val2": "5.14%",
          "chgp": "0.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 1.43% vs 3.85% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs -14.29% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.75",
          "val2": "34.26",
          "chgp": "1.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.31",
          "val2": "1.18",
          "chgp": "11.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.04",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.66",
          "val2": "0.66",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.77%",
          "val2": "3.44%",
          "chgp": "0.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.77% vs 3.21% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 41.38% vs -30.40% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "53.12",
          "val2": "51.69",
          "chgp": "2.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.31",
          "val2": "1.69",
          "chgp": "36.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.06",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.23",
          "val2": "0.87",
          "chgp": "41.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.35%",
          "val2": "3.27%",
          "chgp": "1.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 2.95% vs -0.23% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -3.95% vs -4.40% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "67.28",
          "val2": "65.35",
          "chgp": "2.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.29",
          "val2": "2.49",
          "chgp": "-8.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.08",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.46",
          "val2": "1.52",
          "chgp": "-3.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.40%",
          "val2": "3.81%",
          "chgp": "-0.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
18.37
17.70
3.79%
Operating Profit (PBDIT) excl Other Income
0.99
0.91
8.79%
Interest
0.03
0.03
Exceptional Items
0.00
0.00
Standalone Net Profit
0.56
0.50
12.00%
Operating Profit Margin (Excl OI)
5.39%
5.14%
0.25%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 3.79% vs 3.81% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 12.00% vs 194.12% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
34.75
34.26
1.43%
Operating Profit (PBDIT) excl Other Income
1.31
1.18
11.02%
Interest
0.05
0.04
25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.66
0.66
Operating Profit Margin (Excl OI)
3.77%
3.44%
0.33%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 1.43% vs 3.85% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 0.00% vs -14.29% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
53.12
51.69
2.77%
Operating Profit (PBDIT) excl Other Income
2.31
1.69
36.69%
Interest
0.08
0.06
33.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.23
0.87
41.38%
Operating Profit Margin (Excl OI)
4.35%
3.27%
1.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 2.77% vs 3.21% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 41.38% vs -30.40% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
67.28
65.35
2.95%
Operating Profit (PBDIT) excl Other Income
2.29
2.49
-8.03%
Interest
0.06
0.08
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.46
1.52
-3.95%
Operating Profit Margin (Excl OI)
3.40%
3.81%
-0.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 2.95% vs -0.23% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -3.95% vs -4.40% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sandu Pharmaceuticals Ltd stock-summary
stock-summary
Sandu Pharmaceuticals Ltd
Micro Cap
Trading
Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
Company Coordinates stock-summary
Company Details
Plot No 25/26/29 & 30, Pilerne Indl Estate Marra Bard Bardez Goa : 403511
stock-summary
Tel:
stock-summary
http://www.sandu.in
stock-summary
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."